This inventor holds 1 USPTO granted patent. Top assignee: Hoboomlife Bio-Technology (Shenzhen) Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yuqin Bai: Inventor in Shenzhen
Introduction
Yuqin Bai is an inventor based in Shenzhen, China. Her disclosed patent work concerns a method intended to improve the bioavailability of NAD+ derivatives.
Latest Patents
Bai is associated with 1 patent: “Method for Improving Bioavailability of NAD+ Derivatives.” The disclosure describes combining a CD38 inhibitor and an NAD+ derivative in one preparation. It controls the release so the inhibitor acts first, followed by the NAD+ derivative, with the aim of increasing NAD+ levels in the body.
Career Highlights
Bai is associated with Hoboomlife Bio-Technology (Shenzhen) Co., Ltd. Her patent disclosure focuses on the formulation and release sequence of compounds related to NAD+.
Collaborations
The provided information identifies Jiansheng Chen and Yaying Hou as Bai’s coworkers. It does not specify their roles in the patent or the nature of their collaboration.
Conclusion
Yuqin Bai’s disclosed invention addresses the bioavailability of NAD+ derivatives through a preparation designed to sequence the release of a CD38 inhibitor and the derivative.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile